Author

J. Vilo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:clinical cohort / trial· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:variant calling· 1 Research Focus:variant effect prediction· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

I. Lutsar· 1 shared K. Krebs· 1 shared K. Metsalu· 1 shared L. Milani· 1 shared M. Kals· 1 shared R. Kalamees· 1 shared R. Magi· 1 shared S. Reisberg· 1 shared

Activity by Year

2018-2018 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

I. Lutsar

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

External evaluation of population pharmacokinetic models for vancomycin in neonates

T. Tasa, R. Kalamees, J. Vilo, I. Lutsar, T. Metsvaht

The paper evaluates vancomycin population pharmacokinetic models in neonates using external data, finding wide variation in predictive performance and low attainment of therapeutic targets.

bioRxiv · Oct 31, 2018 · PreprintPharmacology & Toxicology

Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions

S. Reisberg, K. Krebs, M. Kals, R. Magi, K. Metsalu, V. M. Lauschke, J. Vilo, L. Milani

The paper translates genotype data from 44,000 biobank participants into pharmacogenetic recommendations, finding microarrays are cost-effective and exome sequencing is inadequate for this task.

bioRxiv · Jul 4, 2018Pharmacology & Toxicology